This cluster groups 2 independently calculated changes: Cash & equivalents increased 67.4%; Operating cash flow increased 27.6%.
2 evidence-backed components· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTenVVeno Medical Corp's latest supported as-filed period reports revenue of $31,243. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 67.4%; Operating cash flow increased 27.6%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 39.0%; Operating cash flow increased 4.5%.
2 evidence-backed componentsShares outstanding changed -96.5% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
NVNO · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-049269SEC ↗4Sep 14, 2026Period Sep 11, 20260001493152-26-042629SEC ↗10-QJul 30, 2026Period Jun 30, 20260001493152-26-035452SEC ↗8-KJul 14, 2026Period Jul 14, 20260001493152-26-033193SEC ↗4Jun 12, 2026Period Jun 11, 20260001493152-26-028426SEC ↗10-QMay 6, 2026Period Mar 31, 20260001493152-26-021490SEC ↗8-KApr 29, 2026Period Apr 29, 20260001493152-26-019485SEC ↗10-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Shares outstanding changed -96.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Operating income changed +46.1% from the comparable as-filed period.
Operating cash flow changed +27.6% from the comparable as-filed period.
Net income changed +46.2% from the comparable as-filed period.
Current liabilities changed -37.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +67.4% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-012928